Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National Institutes of Health (NIH). The funds will help support the development...
Tag: RABI-767
Lamassu Biotech, the North Carolina-based biopharmaceutical company that opened a Cleveland office last year, has received a $2.7 million grant from the National Institutes of Health to help develop its therapy for...
06/03/2025
SIGNIFICANT NIH GRANT WILL HELP LAMASSU BIOTECH ADVANCE LIFE-SAVING PANCREATITIS TREATMENT FOR DOGS
New ‘One Health’ Grant Could Help Man’s Best Friend with Groundbreaking Researchfor Presently Untreatable Condition, Provide Key Data for Human Treatment (CLEVELAND, OH) – Momentum continues to build for Lamassu...